Article
ACSL4 knockdown inhibits colorectal cancer progression through stimulating anti-tumor immunity
11 Jun 2025
Abstract excerpt
BACKGROUND: Long-chain acyl-CoA synthetase 4 (ACSL4), a crucial modulator of ferroptosis, is associated with tumor progression, though its impact on colorectal cancer (CRC) immune dynamics is not fully understood. METHODS: ACSL4 expression was analyzed in CRC tissues and correlated with patient prognosis. Effects of ACSL4 were evaluated in CRC cells in vitro and in subcutaneous and orthotopic CRC models. Flow...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
